HCA Healthcare (NYSE:HCA) Now Covered by Deutsche Bank

Deutsche Bank began coverage on shares of HCA Healthcare (NYSE:HCA) in a research note issued to investors on Thursday, January 3rd, MarketBeat Ratings reports. The firm issued a buy rating and a $140.00 price target on the stock.

A number of other research firms have also weighed in on HCA. Zacks Investment Research raised shares of HCA Healthcare from a hold rating to a buy rating and set a $157.00 target price for the company in a research report on Monday, November 19th. Citigroup upped their price objective on shares of HCA Healthcare from $136.00 to $156.00 and gave the company a buy rating in a research report on Thursday, October 11th. Royal Bank of Canada upped their price objective on shares of HCA Healthcare to $150.00 and gave the company an outperform rating in a research report on Monday, September 10th. Bank of America upped their price objective on shares of HCA Healthcare from $125.00 to $135.00 and gave the company an underperform rating in a research report on Tuesday, September 18th. Finally, UBS Group began coverage on shares of HCA Healthcare in a research report on Thursday, November 15th. They issued a buy rating and a $162.00 price target for the company. Two equities research analysts have rated the stock with a sell rating, four have issued a hold rating and seventeen have issued a buy rating to the stock. HCA Healthcare has a consensus rating of Buy and a consensus price target of $143.14.

Shares of HCA stock opened at $129.14 on Thursday. The company has a market capitalization of $44.16 billion, a price-to-earnings ratio of 19.60, a P/E/G ratio of 1.04 and a beta of 0.69. HCA Healthcare has a 52 week low of $86.72 and a 52 week high of $147.42.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings results on Tuesday, October 30th. The company reported $2.16 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.93 by $0.23. HCA Healthcare had a negative return on equity of 73.71% and a net margin of 6.82%. The company had revenue of $11.45 billion for the quarter, compared to analysts’ expectations of $11.29 billion. During the same quarter in the prior year, the company earned $1.13 earnings per share. The firm’s revenue was up 7.1% on a year-over-year basis. Equities research analysts predict that HCA Healthcare will post 9.33 EPS for the current year.

The company also recently disclosed a quarterly dividend, which was paid on Friday, December 28th. Stockholders of record on Monday, December 3rd were given a $0.35 dividend. This represents a $1.40 dividend on an annualized basis and a dividend yield of 1.08%. The ex-dividend date was Friday, November 30th. HCA Healthcare’s dividend payout ratio (DPR) is presently 21.24%.

In other news, SVP Deborah M. Reiner sold 723 shares of the business’s stock in a transaction that occurred on Monday, November 5th. The shares were sold at an average price of $135.06, for a total value of $97,648.38. Following the completion of the transaction, the senior vice president now directly owns 6,184 shares in the company, valued at approximately $835,211.04. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, insider Michael S. Cuffe sold 5,196 shares of the business’s stock in a transaction that occurred on Friday, November 2nd. The shares were sold at an average price of $136.52, for a total transaction of $709,357.92. The disclosure for this sale can be found here. Insiders have sold a total of 16,763 shares of company stock valued at $2,346,147 in the last ninety days. 2.80% of the stock is currently owned by insiders.

Large investors have recently modified their holdings of the company. Moody National Bank Trust Division acquired a new position in shares of HCA Healthcare in the 4th quarter valued at approximately $27,000. Csenge Advisory Group bought a new stake in shares of HCA Healthcare during the 3rd quarter valued at approximately $48,000. Bamco Inc. NY bought a new stake in shares of HCA Healthcare during the 3rd quarter valued at approximately $169,000. Glenmede Trust Co. NA grew its holdings in shares of HCA Healthcare by 164.9% during the 3rd quarter. Glenmede Trust Co. NA now owns 1,274 shares of the company’s stock valued at $176,000 after purchasing an additional 793 shares during the last quarter. Finally, Smithfield Trust Co. grew its holdings in shares of HCA Healthcare by 41.2% during the 3rd quarter. Smithfield Trust Co. now owns 1,405 shares of the company’s stock valued at $196,000 after purchasing an additional 410 shares during the last quarter. Institutional investors own 69.82% of the company’s stock.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.

Further Reading: What are retained earnings?

Analyst Recommendations for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply